BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12538158)

  • 1. CD30-governor of memory T cells?
    Podack ER; Strbo N; Sotosec V; Muta H
    Ann N Y Acad Sci; 2002 Dec; 975():101-13. PubMed ID: 12538158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD30 signals integrate expression of cytotoxic effector molecules, lymphocyte trafficking signals, and signals for proliferation and apoptosis.
    Muta H; Boise LH; Fang L; Podack ER
    J Immunol; 2000 Nov; 165(9):5105-11. PubMed ID: 11046041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel role of CD30/CD30 ligand signaling in the generation of long-lived memory CD8+ T cells.
    Nishimura H; Yajima T; Muta H; Podack ER; Tani K; Yoshikai Y
    J Immunol; 2005 Oct; 175(7):4627-34. PubMed ID: 16177108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mice deficient in OX40 and CD30 signals lack memory antibody responses because of deficient CD4 T cell memory.
    Gaspal FM; Kim MY; McConnell FM; Raykundalia C; Bekiaris V; Lane PJ
    J Immunol; 2005 Apr; 174(7):3891-6. PubMed ID: 15778343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CD30 in B/T segregation in the spleen.
    Bekiaris V; Withers D; Glanville SH; McConnell FM; Parnell SM; Kim MY; Gaspal FM; Jenkinson E; Sweet C; Anderson G; Lane PJ
    J Immunol; 2007 Dec; 179(11):7535-43. PubMed ID: 18025198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8 T cell memory in B cell-deficient mice.
    Asano MS; Ahmed R
    J Exp Med; 1996 May; 183(5):2165-74. PubMed ID: 8642326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD30: from basic research to cancer therapy.
    Muta H; Podack ER
    Immunol Res; 2013 Dec; 57(1-3):151-8. PubMed ID: 24233555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD30 triggering by agonistic antibodies regulates CXCR4 expression and CXCL12 chemotactic activity in the cell line L540.
    Vinante F; Rigo A; Scupoli MT; Pizzolo G
    Blood; 2002 Jan; 99(1):52-60. PubMed ID: 11756152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mRNA expression patterns indicate CD30 mediated activation of different apoptosis pathways in anaplastic large cell lymphoma but not in Hodgkin's lymphoma.
    Staber PB; Noehammer C; Dürkop H; Schauer S; Kenner L; Linkesch W; Hoefler G
    Leuk Res; 2006 Mar; 30(3):343-8. PubMed ID: 16198418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD30 prevents T-cell responses to non-lymphoid tissues.
    Heath WR; Kurts C; Caminschi I; Carbone FR; Miller JF
    Immunol Rev; 1999 Jun; 169():23-9. PubMed ID: 10450505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of CCR7 on priming and distribution of antiviral effector and memory CTL.
    Junt T; Scandella E; Förster R; Krebs P; Krautwald S; Lipp M; Hengartner H; Ludewig B
    J Immunol; 2004 Dec; 173(11):6684-93. PubMed ID: 15557160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD30L up-regulates CD30 and IL-4 expression by T cells.
    Rossi FM; Degan M; Mazzocut-Zecchin L; Di Francia R; Aldinucci D; Pinto A; Gattei V
    FEBS Lett; 2001 Nov; 508(3):418-22. PubMed ID: 11728464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical roles of CD30/CD30L interactions in murine autoimmune diabetes.
    Chakrabarty S; Nagata M; Yasuda H; Wen L; Nakayama M; Chowdhury SA; Yamada K; Jin Z; Kotani R; Moriyama H; Shimozato O; Yagita H; Yokono K
    Clin Exp Immunol; 2003 Sep; 133(3):318-25. PubMed ID: 12930356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic OX40 and CD30 signals sustain CD8+ T cells during antigenic challenge.
    Bekiaris V; Gaspal F; Kim MY; Withers DR; Sweet C; Anderson G; Lane PJ
    Eur J Immunol; 2009 Aug; 39(8):2120-5. PubMed ID: 19609980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic CD30 signaling in B cells results in lymphomagenesis by driving the expansion of plasmablasts and B1 cells.
    Sperling S; Fiedler P; Lechner M; Pollithy A; Ehrenberg S; Schiefer AI; Kenner L; Feuchtinger A; Kühn R; Swinerd G; Schmidt-Supprian M; Strobl LJ; Zimber-Strobl U
    Blood; 2019 Jun; 133(24):2597-2609. PubMed ID: 30962205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD30 plays a role in T-dependent immune response and T cell proliferation.
    Cui D; Zhang Y; Chen L; Du H; Zheng B; Huang M; Li X; Wei J; Chen Q
    FASEB J; 2024 Jan; 38(1):e23365. PubMed ID: 38069862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells.
    Gruss H-J ; Herrmann F
    Leuk Lymphoma; 1996 Feb; 20(5-6):397-409. PubMed ID: 8833395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD30+ T Cells in Late Seroma May Not Be Diagnostic of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Kadin ME; Morgan J; Xu H; Glicksman CA
    Aesthet Surg J; 2017 Jul; 37(7):771-775. PubMed ID: 28402493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines.
    Gilfillan MC; Noel PJ; Podack ER; Reiner SL; Thompson CB
    J Immunol; 1998 Mar; 160(5):2180-7. PubMed ID: 9498756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-induced polyclonal B cell activation improves protective CTL memory via retained CD27 expression on memory CTL.
    Matter M; Mumprecht S; Pinschewer DD; Pavelic V; Yagita H; Krautwald S; Borst J; Ochsenbein AF
    Eur J Immunol; 2005 Nov; 35(11):3229-39. PubMed ID: 16231287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.